Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Jul;85(14):5249–5253. doi: 10.1073/pnas.85.14.5249

Photophysical studies of tin(IV)-protoporphyrin: potential phototoxicity of a chemotherapeutic agent proposed for the prevention of neonatal jaundice.

E J Land 1, A F McDonagh 1, D J McGarvey 1, T G Truscott 1
PMCID: PMC281727  PMID: 3393537

Abstract

The strongly light-absorbing metalloporphyrin tin(IV)-protoporphyrin IX (SnPP) is currently being considered as a chemotherapeutic agent for preventing severe hyperbilirubinemia in newborns, a condition usually treated by phototherapy with visible light. To assess the potential phototoxicity of SnPP we studied the photophysics of the drug in aqueous and nonaqueous solutions using laser flash photolysis and pulse radiolysis. Quantum yields for formation of triplet-state excited SnPP were measured, along with triplet lifetimes and extinction coefficients. In addition, we measured quantum yields for the SnPP-photosensitized formation of singlet oxygen in MeO2H and 2H2O containing cetyltrimethylammonium bromide, using a time-resolved luminescence technique. Quantum yields for formation of triplet SnPP from monomeric ground-state SnPP are high (approximately equal to 0.6-0.8), and triplet lifetimes are long (approximately equal to 0.1-0.2 ms). Efficient quenching of triplet SnPP by molecular oxygen was seen with rate constants greater than 10(9) M-1.s-1. SnPP-photosensitized formation of singlet oxygen in aqueous and nonaqueous solvents was confirmed by the detection of the characteristic luminescence at 1270 nm (phi delta = 0.58 in MeO2H). The photophysical parameters and singlet oxygen-sensitizing efficiency of SnPP are similar to those reported for hematoporphyrin and other metal-free porphyrins known to be phototoxic to humans. These observations suggest that cutaneous photosensitivity arising from singlet-oxygen damage is likely to be an undesirable side-effect of SnPP therapy.

Full text

PDF
5249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. E., Simionatto C. S., Drummond G. S., Kappas A. Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans. Clin Pharmacol Ther. 1986 May;39(5):510–520. doi: 10.1038/clpt.1986.88. [DOI] [PubMed] [Google Scholar]
  2. Anderson K. E., Simionatto C. S., Drummond G. S., Kappas A. Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase. J Pharmacol Exp Ther. 1984 Feb;228(2):327–333. [PubMed] [Google Scholar]
  3. Barboy N., Feitelson J. Quenching of the zinc-protoporphyrin triplet state as a measure of small-molecule diffusion through the structure of myoglobin. Biochemistry. 1987 Jun 2;26(11):3240–3244. doi: 10.1021/bi00385a046. [DOI] [PubMed] [Google Scholar]
  4. Breslow E., Chandra R., Kappas A. Biochemical properties of the heme oxygenase inhibitor, Sn-protoporphyrin. Interactions with apomyoglobin and human serum albumin. J Biol Chem. 1986 Mar 5;261(7):3135–3141. [PubMed] [Google Scholar]
  5. Delaney J. K., Mauzerall D., Drummond G. S., Kappas A. Photophysical properties of Sn-porphyrins: potential clinical implications. Pediatrics. 1988 Apr;81(4):498–504. [PubMed] [Google Scholar]
  6. Drummond G. S., Galbraith R. A., Sardana M. K., Kappas A. Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism. Arch Biochem Biophys. 1987 May 15;255(1):64–74. doi: 10.1016/0003-9861(87)90294-3. [DOI] [PubMed] [Google Scholar]
  7. Eggert L. D., Pollary R. A., Folland D. S., Jung A. L. Home phototherapy treatment of neonatal jaundice. Pediatrics. 1985 Oct;76(4):579–584. [PubMed] [Google Scholar]
  8. Kappas A., Drummond G. S. Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest. 1986 Feb;77(2):335–339. doi: 10.1172/JCI112309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kappas A., Drummond G. S., Manola T., Petmezaki S., Valaes T. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics. 1988 Apr;81(4):485–497. [PubMed] [Google Scholar]
  10. Kappas A., Drummond G. S., Simionatto C. S., Anderson K. E. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin. Hepatology. 1984 Mar-Apr;4(2):336–341. doi: 10.1002/hep.1840040227. [DOI] [PubMed] [Google Scholar]
  11. Keene J. P., Kessel D., Land E. J., Redmond R. W., Truscott T. G. Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds. Photochem Photobiol. 1986 Feb;43(2):117–120. doi: 10.1111/j.1751-1097.1986.tb09501.x. [DOI] [PubMed] [Google Scholar]
  12. Lambert C. R., Reddi E., Spikes J. D., Rodgers M. A., Jori G. The effects of porphyrin structure and aggregation state on photosensitized processes in aqueous and micellar media. Photochem Photobiol. 1986 Nov;44(5):595–601. doi: 10.1111/j.1751-1097.1986.tb04714.x. [DOI] [PubMed] [Google Scholar]
  13. Landry R. J., Scheidt P. C., Hammond R. W. Ambient light and phototherapy conditions of eight neonatal care units: a summary report. Pediatrics. 1985 Feb;75(2 Pt 2):434–436. [PubMed] [Google Scholar]
  14. McDonagh A. F., Lightner D. A. 'Like a shrivelled blood orange'--bilirubin, jaundice, and phototherapy. Pediatrics. 1985 Mar;75(3):443–455. [PubMed] [Google Scholar]
  15. McDonagh A. F., Palma L. A. Tin-protoporphyrin: a potent photosensitizer of bilirubin destruction. Photochem Photobiol. 1985 Sep;42(3):261–264. doi: 10.1111/j.1751-1097.1985.tb08940.x. [DOI] [PubMed] [Google Scholar]
  16. McDonagh A. F. The role of singlet oxygen in bilirubin photo-oxidation. Biochem Biophys Res Commun. 1971 Sep 17;44(6):1306–1311. doi: 10.1016/s0006-291x(71)80228-0. [DOI] [PubMed] [Google Scholar]
  17. Poh-Fitzpatrick M. B. Pathogenesis and treatment of photocutaneous manifestations of the porphyrias. Semin Liver Dis. 1982 May;2(2):164–176. doi: 10.1055/s-2008-1040706. [DOI] [PubMed] [Google Scholar]
  18. Redmond R. W., Heihoff K., Braslavsky S. E., Truscott T. G. Thermal-lensing and phosphorescence studies of the quantum yield and lifetime of singlet molecular oxygen (1 delta g) sensitized by hematoporphyrin and related porphyrins in deuterated and non-deuterated ethanols. Photochem Photobiol. 1987 Feb;45(2):209–213. doi: 10.1111/j.1751-1097.1987.tb05365.x. [DOI] [PubMed] [Google Scholar]
  19. Sardana M. K., Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2464–2468. doi: 10.1073/pnas.84.8.2464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N., Ames B. N. Bilirubin is an antioxidant of possible physiological importance. Science. 1987 Feb 27;235(4792):1043–1046. doi: 10.1126/science.3029864. [DOI] [PubMed] [Google Scholar]
  21. Swick H. M., Cunningham M. D., Shield L. K. Transillumination of the skull in premature infants. Pediatrics. 1976 Nov;58(5):658–664. [PubMed] [Google Scholar]
  22. Tönz O., Vogt J., Filippini L., Simmler F., Wachsmuth E. D., Winterhalter K. H. Schwere Lichtdermatose nach Phototherapie bei einem Neugeborenen mit kongenitaler erythropoietischer Uroporphyrie. Helv Paediatr Acta. 1975 May;30(1):47–56. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES